 | • レポートコード：GIR201113392 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、リソソームアルファグルコシダーゼの世界市場を調査対象にし、リソソームアルファグルコシダーゼの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他）、用途別分析（糖原病、ポンペ病、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amicus Therapeutics Inc、Oxyrane Belgium NV、Genzyme Corp、Audentes Therapeutics Inc、JCR Pharmaceuticals Co Ltd、Etubics Corp、Sarepta Therapeutics Inc、Huons Co Ltd、greenovation Biotech GmbH、Pharming Group NV ・メーカー別販売量、売上、市場シェア ・リソソームアルファグルコシダーゼの地域別市場分析 ・リソソームアルファグルコシダーゼの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・リソソームアルファグルコシダーゼのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・リソソームアルファグルコシダーゼのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・リソソームアルファグルコシダーゼの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・リソソームアルファグルコシダーゼの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・リソソームアルファグルコシダーゼの種類別市場規模2015-2020：AT-982、ATB-200、AVRRD-03、JR-162、MOSS-GAA、OXY-2810、その他 ・リソソームアルファグルコシダーゼの用途別市場規模2015-2020：糖原病、ポンペ病、その他 ・リソソームアルファグルコシダーゼの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Lysosomal Alpha Glucosidase market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Lysosomal Alpha Glucosidase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lysosomal Alpha Glucosidase market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lysosomal Alpha Glucosidase market has been segmented into
AT-982
ATB-200
AVRRD-03
JR-162
MOSS-GAA
OXY-2810
Others
By Application, Lysosomal Alpha Glucosidase has been segmented into:
Glycogen Storage Disease
Pompe Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lysosomal Alpha Glucosidase market presented in the report. This section sheds light on the sales growth of different regional and country-level Lysosomal Alpha Glucosidase markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lysosomal Alpha Glucosidase market.
The report offers in-depth assessment of the growth and other aspects of the Lysosomal Alpha Glucosidase market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Lysosomal Alpha Glucosidase Market Share Analysis
Lysosomal Alpha Glucosidase competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lysosomal Alpha Glucosidase sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lysosomal Alpha Glucosidase sales, revenue and market share for each player covered in this report.
The major players covered in Lysosomal Alpha Glucosidase are:
Amicus Therapeutics Inc
Oxyrane Belgium NV
Genzyme Corp
Audentes Therapeutics Inc
JCR Pharmaceuticals Co Ltd
Etubics Corp
Sarepta Therapeutics Inc
Huons Co Ltd
greenovation Biotech GmbH
Pharming Group NV
Among other players domestic and global, Lysosomal Alpha Glucosidase market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lysosomal Alpha Glucosidase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lysosomal Alpha Glucosidase, with price, sales, revenue and global market share of Lysosomal Alpha Glucosidase in 2018 and 2019.
Chapter 3, the Lysosomal Alpha Glucosidase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lysosomal Alpha Glucosidase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lysosomal Alpha Glucosidase market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lysosomal Alpha Glucosidase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Lysosomal Alpha Glucosidase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lysosomal Alpha Glucosidase Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AT-982
1.2.3 ATB-200
1.2.4 AVRRD-03
1.2.5 JR-162
1.2.6 MOSS-GAA
1.2.7 OXY-2810
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Lysosomal Alpha Glucosidase Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Glycogen Storage Disease
1.3.3 Pompe Disease
1.3.4 Others
1.4 Overview of Global Lysosomal Alpha Glucosidase Market
1.4.1 Global Lysosomal Alpha Glucosidase Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amicus Therapeutics Inc
2.1.1 Amicus Therapeutics Inc Details
2.1.2 Amicus Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amicus Therapeutics Inc SWOT Analysis
2.1.4 Amicus Therapeutics Inc Product and Services
2.1.5 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Oxyrane Belgium NV
2.2.1 Oxyrane Belgium NV Details
2.2.2 Oxyrane Belgium NV Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Oxyrane Belgium NV SWOT Analysis
2.2.4 Oxyrane Belgium NV Product and Services
2.2.5 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Genzyme Corp
2.3.1 Genzyme Corp Details
2.3.2 Genzyme Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Genzyme Corp SWOT Analysis
2.3.4 Genzyme Corp Product and Services
2.3.5 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Audentes Therapeutics Inc
2.4.1 Audentes Therapeutics Inc Details
2.4.2 Audentes Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Audentes Therapeutics Inc SWOT Analysis
2.4.4 Audentes Therapeutics Inc Product and Services
2.4.5 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 JCR Pharmaceuticals Co Ltd
2.5.1 JCR Pharmaceuticals Co Ltd Details
2.5.2 JCR Pharmaceuticals Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 JCR Pharmaceuticals Co Ltd SWOT Analysis
2.5.4 JCR Pharmaceuticals Co Ltd Product and Services
2.5.5 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Etubics Corp
2.6.1 Etubics Corp Details
2.6.2 Etubics Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Etubics Corp SWOT Analysis
2.6.4 Etubics Corp Product and Services
2.6.5 Etubics Corp Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sarepta Therapeutics Inc
2.7.1 Sarepta Therapeutics Inc Details
2.7.2 Sarepta Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sarepta Therapeutics Inc SWOT Analysis
2.7.4 Sarepta Therapeutics Inc Product and Services
2.7.5 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Huons Co Ltd
2.8.1 Huons Co Ltd Details
2.8.2 Huons Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Huons Co Ltd SWOT Analysis
2.8.4 Huons Co Ltd Product and Services
2.8.5 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 greenovation Biotech GmbH
2.9.1 greenovation Biotech GmbH Details
2.9.2 greenovation Biotech GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 greenovation Biotech GmbH SWOT Analysis
2.9.4 greenovation Biotech GmbH Product and Services
2.9.5 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pharming Group NV
2.10.1 Pharming Group NV Details
2.10.2 Pharming Group NV Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pharming Group NV SWOT Analysis
2.10.4 Pharming Group NV Product and Services
2.10.5 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lysosomal Alpha Glucosidase Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lysosomal Alpha Glucosidase Manufacturer Market Share in 2019
3.3.2 Top 6 Lysosomal Alpha Glucosidase Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lysosomal Alpha Glucosidase Sales, Revenue and Market Share by Regions
4.1.1 Global Lysosomal Alpha Glucosidase Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Regions (2015-2020)
4.2 North America Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
4.3 Europe Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
4.5 South America Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lysosomal Alpha Glucosidase Sales, Revenue and Market Share by Country
5.1.1 North America Lysosomal Alpha Glucosidase Sales and Market Share by Country (2015-2020)
5.1.2 North America Lysosomal Alpha Glucosidase Revenue and Market Share by Country (2015-2020)
5.2 United States Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
5.3 Canada Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
5.4 Mexico Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lysosomal Alpha Glucosidase Sales, Revenue and Market Share by Country
6.1.1 Europe Lysosomal Alpha Glucosidase Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lysosomal Alpha Glucosidase Revenue and Market Share by Country (2015-2020)
6.2 Germany Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
6.3 UK Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
6.4 France Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
6.5 Russia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
6.6 Italy Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lysosomal Alpha Glucosidase Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lysosomal Alpha Glucosidase Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lysosomal Alpha Glucosidase Revenue and Market Share by Regions (2015-2020)
7.2 China Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
7.3 Japan Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
7.4 Korea Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
7.5 India Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
7.7 Australia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lysosomal Alpha Glucosidase Sales, Revenue and Market Share by Country
8.1.1 South America Lysosomal Alpha Glucosidase Sales and Market Share by Country (2015-2020)
8.1.2 South America Lysosomal Alpha Glucosidase Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
8.3 Argentina Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lysosomal Alpha Glucosidase Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lysosomal Alpha Glucosidase Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lysosomal Alpha Glucosidase Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
9.3 Turkey Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
9.4 Egypt Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
9.5 South Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lysosomal Alpha Glucosidase Sales and Market Share by Type (2015-2020)
10.2 Global Lysosomal Alpha Glucosidase Revenue and Market Share by Type (2015-2020)
10.3 Global Lysosomal Alpha Glucosidase Price by Type (2015-2020)
11 Global Lysosomal Alpha Glucosidase Market Segment by Application
11.1 Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2015-2020)
11.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2015-2020)
11.3 Global Lysosomal Alpha Glucosidase Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lysosomal Alpha Glucosidase Sales, Revenue and Growth Rate (2021-2025)
12.2 Lysosomal Alpha Glucosidase Market Forecast by Regions (2021-2025)
12.2.1 North America Lysosomal Alpha Glucosidase Market Forecast (2021-2025)
12.2.2 Europe Lysosomal Alpha Glucosidase Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lysosomal Alpha Glucosidase Market Forecast (2021-2025)
12.2.4 South America Lysosomal Alpha Glucosidase Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lysosomal Alpha Glucosidase Market Forecast (2021-2025)
12.3 Lysosomal Alpha Glucosidase Market Forecast by Type (2021-2025)
12.3.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2021-2025)
12.3.2 Global Lysosomal Alpha Glucosidase Market Share Forecast by Type (2021-2025)
12.4 Lysosomal Alpha Glucosidase Market Forecast by Application (2021-2025)
12.4.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2021-2025)
12.4.2 Global Lysosomal Alpha Glucosidase Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Lysosomal Alpha Glucosidase Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lysosomal Alpha Glucosidase by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lysosomal Alpha Glucosidase Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amicus Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Major Business
Table 9. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 10. Amicus Therapeutics Inc SWOT Analysis
Table 11. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product and Services
Table 12. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Oxyrane Belgium NV Basic Information, Manufacturing Base and Competitors
Table 14. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Major Business
Table 15. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 16. Oxyrane Belgium NV SWOT Analysis
Table 17. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product and Services
Table 18. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Genzyme Corp Basic Information, Manufacturing Base and Competitors
Table 20. Genzyme Corp Lysosomal Alpha Glucosidase Major Business
Table 21. Genzyme Corp Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 22. Genzyme Corp SWOT Analysis
Table 23. Genzyme Corp Lysosomal Alpha Glucosidase Product and Services
Table 24. Genzyme Corp Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Audentes Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 26. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Major Business
Table 27. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 28. Audentes Therapeutics Inc SWOT Analysis
Table 29. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product and Services
Table 30. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. JCR Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 32. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Major Business
Table 33. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 34. JCR Pharmaceuticals Co Ltd SWOT Analysis
Table 35. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product and Services
Table 36. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Etubics Corp Basic Information, Manufacturing Base and Competitors
Table 38. Etubics Corp Lysosomal Alpha Glucosidase Major Business
Table 39. Etubics Corp Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 40. Etubics Corp SWOT Analysis
Table 41. Etubics Corp Lysosomal Alpha Glucosidase Product and Services
Table 42. Etubics Corp Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sarepta Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 44. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Major Business
Table 45. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 46. Sarepta Therapeutics Inc SWOT Analysis
Table 47. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product and Services
Table 48. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Huons Co Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Huons Co Ltd Lysosomal Alpha Glucosidase Major Business
Table 51. Huons Co Ltd Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 52. Huons Co Ltd SWOT Analysis
Table 53. Huons Co Ltd Lysosomal Alpha Glucosidase Product and Services
Table 54. Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. greenovation Biotech GmbH Basic Information, Manufacturing Base and Competitors
Table 56. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Major Business
Table 57. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 58. greenovation Biotech GmbH SWOT Analysis
Table 59. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product and Services
Table 60. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table 62. Pharming Group NV Lysosomal Alpha Glucosidase Major Business
Table 63. Pharming Group NV Lysosomal Alpha Glucosidase Total Revenue (USD Million) (2018-2019)
Table 64. Pharming Group NV SWOT Analysis
Table 65. Pharming Group NV Lysosomal Alpha Glucosidase Product and Services
Table 66. Pharming Group NV Lysosomal Alpha Glucosidase Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Lysosomal Alpha Glucosidase Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Lysosomal Alpha Glucosidase Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Lysosomal Alpha Glucosidase Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Lysosomal Alpha Glucosidase Sales Market Share by Regions (2015-2020)
Table 71. Global Lysosomal Alpha Glucosidase Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Lysosomal Alpha Glucosidase Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Lysosomal Alpha Glucosidase Sales Market Share by Countries (2015-2020)
Table 74. North America Lysosomal Alpha Glucosidase Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Lysosomal Alpha Glucosidase Revenue Market Share by Countries (2015-2020)
Table 76. Europe Lysosomal Alpha Glucosidase Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Lysosomal Alpha Glucosidase Sales Market Share by Countries (2015-2020)
Table 78. Europe Lysosomal Alpha Glucosidase Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Lysosomal Alpha Glucosidase Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Lysosomal Alpha Glucosidase Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Lysosomal Alpha Glucosidase Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Lysosomal Alpha Glucosidase Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Lysosomal Alpha Glucosidase Sales Market Share by Countries (2015-2020)
Table 84. South America Lysosomal Alpha Glucosidase Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Lysosomal Alpha Glucosidase Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Lysosomal Alpha Glucosidase Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Lysosomal Alpha Glucosidase Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Lysosomal Alpha Glucosidase Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Lysosomal Alpha Glucosidase Revenue Market Share by Countries (2015-2020)
Table 90. Global Lysosomal Alpha Glucosidase Sales by Type (2015-2020) (K Pcs)
Table 91. Global Lysosomal Alpha Glucosidase Sales Share by Type (2015-2020)
Table 92. Global Lysosomal Alpha Glucosidase Revenue by Type (2015-2020) (USD Million)
Table 93. Global Lysosomal Alpha Glucosidase Revenue Share by Type (2015-2020)
Table 94. Global Lysosomal Alpha Glucosidase Sales by Application (2015-2020) (K Pcs)
Table 95. Global Lysosomal Alpha Glucosidase Sales Share by Application (2015-2020)
Table 96. Global Lysosomal Alpha Glucosidase Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Lysosomal Alpha Glucosidase Market Share Forecast by Regions (2021-2025)
Table 98. Global Lysosomal Alpha Glucosidase Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Lysosomal Alpha Glucosidase Market Share Forecast by Type (2021-2025)
Table 100. Global Lysosomal Alpha Glucosidase Sales Forecast by Application (2021-2025)
Table 101. Global Lysosomal Alpha Glucosidase Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lysosomal Alpha Glucosidase Picture
Figure 2. Global Sales Market Share of Lysosomal Alpha Glucosidase by Type in 2019
Figure 3. AT-982 Picture
Figure 4. ATB-200 Picture
Figure 5. AVRRD-03 Picture
Figure 6. JR-162 Picture
Figure 7. MOSS-GAA Picture
Figure 8. OXY-2810 Picture
Figure 9. Others Picture
Figure 10. Lysosomal Alpha Glucosidase Sales Market Share by Application in 2018
Figure 11. Glycogen Storage Disease Picture
Figure 12. Pompe Disease Picture
Figure 13. Others Picture
Figure 14. Global Lysosomal Alpha Glucosidase Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Lysosomal Alpha Glucosidase Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturer in 2019
Figure 35. Global Lysosomal Alpha Glucosidase Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Lysosomal Alpha Glucosidase Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Lysosomal Alpha Glucosidase Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Lysosomal Alpha Glucosidase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Lysosomal Alpha Glucosidase Revenue Market Share by Regions (2015-2020)
Figure 42. Global Lysosomal Alpha Glucosidase Revenue Market Share by Regions in 2018
Figure 43. North America Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
Figure 44. Europe Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
Figure 46. South America Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020)
Figure 48. North America Lysosomal Alpha Glucosidase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Lysosomal Alpha Glucosidase Sales Market Share by Countries (2015-2020)
Figure 50. North America Lysosomal Alpha Glucosidase Sales Market Share by Countries in 2018
Figure 51. North America Lysosomal Alpha Glucosidase Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Lysosomal Alpha Glucosidase Revenue Market Share by Countries in 2018
Figure 53. United States Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Lysosomal Alpha Glucosidase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Lysosomal Alpha Glucosidase Revenue Market Share by Countries in 2019
Figure 59. Germany Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Lysosomal Alpha Glucosidase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Lysosomal Alpha Glucosidase Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Lysosomal Alpha Glucosidase Revenue Market Share by Regions 2019
Figure 67. China Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Lysosomal Alpha Glucosidase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Lysosomal Alpha Glucosidase Sales Market Share by Countries in 2019
Figure 74. South America Lysosomal Alpha Glucosidase Revenue Market Share by Countries in 2019
Figure 75. Brazil Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Lysosomal Alpha Glucosidase Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Lysosomal Alpha Glucosidase Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Lysosomal Alpha Glucosidase Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Lysosomal Alpha Glucosidase Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Lysosomal Alpha Glucosidase Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Lysosomal Alpha Glucosidase Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Lysosomal Alpha Glucosidase Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Lysosomal Alpha Glucosidase Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Lysosomal Alpha Glucosidase Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Lysosomal Alpha Glucosidase Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
アルファガラクトシダーゼAの世界市場 2020年 Market Overview The global Alpha Galactosidase A market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha Galactosidase A m…- ポンペ病治療の世界市場 2020年 Market Overview The global Pompe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1052.4 million by 2025, from USD 972.6 million in 2019. The Pompe Disease…
- インターロイキン1アルファの世界市場 2020年 Market Overview The global Interleukin 1 Alpha market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Interleukin 1 Alpha marke…
- インテグリンアルファVの世界市場 2020年 Market Overview The global Integrin Alpha V market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Integrin Alpha V market repo…
- アルファ2Cアドレナリン受容体の世界市場 2020年 Market Overview The global Alpha 2C Adrenergic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha 2C Adrener…